nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—SLC22A5—Dactinomycin—kidney cancer	0.129	0.193	CbGbCtD
Lomefloxacin—TOP2A—Doxorubicin—kidney cancer	0.0943	0.141	CbGbCtD
Lomefloxacin—ABCC2—Paclitaxel—kidney cancer	0.0718	0.107	CbGbCtD
Lomefloxacin—ABCC2—Sorafenib—kidney cancer	0.0638	0.0954	CbGbCtD
Lomefloxacin—ABCC2—Vinblastine—kidney cancer	0.063	0.0942	CbGbCtD
Lomefloxacin—ABCC2—Vincristine—kidney cancer	0.0619	0.0927	CbGbCtD
Lomefloxacin—ABCC2—Sunitinib—kidney cancer	0.0517	0.0773	CbGbCtD
Lomefloxacin—CYP1A2—Pazopanib—kidney cancer	0.041	0.0613	CbGbCtD
Lomefloxacin—ABCC2—Doxorubicin—kidney cancer	0.0387	0.0579	CbGbCtD
Lomefloxacin—CYP1A2—Erlotinib—kidney cancer	0.0292	0.0438	CbGbCtD
Lomefloxacin—CYP1A2—Sorafenib—kidney cancer	0.0238	0.0356	CbGbCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 1—TPX2—kidney cancer	0.00212	0.0761	CbGpPWpGaD
Lomefloxacin—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.00196	0.296	CbGdCrCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—HLTF—kidney cancer	0.00137	0.049	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FOSL2—kidney cancer	0.00128	0.0461	CbGpPWpGaD
Lomefloxacin—TOP2A—Docetaxel—Paclitaxel—kidney cancer	0.00106	0.16	CbGdCrCtD
Lomefloxacin—ABCC2—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.00103	0.0371	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aflatoxin activation and detoxification—ACY1—kidney cancer	0.00092	0.033	CbGpPWpGaD
Lomefloxacin—ABCC2—Irinotecan Pathway—BCHE—kidney cancer	0.000878	0.0315	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 1—AURKA—kidney cancer	0.000718	0.0257	CbGpPWpGaD
Lomefloxacin—CYP1A2—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000578	0.0207	CbGpPWpGaD
Lomefloxacin—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000566	0.0203	CbGpPWpGaD
Lomefloxacin—TOP2A—Vindesine—Vinblastine—kidney cancer	0.000537	0.0812	CbGdCrCtD
Lomefloxacin—TOP2A—Vindesine—Vincristine—kidney cancer	0.000537	0.0812	CbGdCrCtD
Lomefloxacin—TOP2A—Gefitinib—Erlotinib—kidney cancer	0.000506	0.0765	CbGdCrCtD
Lomefloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000478	0.0171	CbGpPWpGaD
Lomefloxacin—ABCC2—Irinotecan Pathway—APC—kidney cancer	0.000476	0.0171	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—kidney cancer	0.000419	0.015	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 1—APC—kidney cancer	0.00038	0.0136	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—kidney cancer	0.00037	0.0133	CbGpPWpGaD
Lomefloxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—kidney cancer	0.000357	0.0128	CbGpPWpGaD
Lomefloxacin—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000341	0.0122	CbGpPWpGaD
Lomefloxacin—TOP2A—Vinorelbine—Vincristine—kidney cancer	0.000339	0.0513	CbGdCrCtD
Lomefloxacin—TOP2A—Vinorelbine—Vinblastine—kidney cancer	0.000339	0.0513	CbGdCrCtD
Lomefloxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—kidney cancer	0.000325	0.0117	CbGpPWpGaD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000325	0.0117	CbGpPWpGaD
Lomefloxacin—ABCC2—ABC-family proteins mediated transport—ABCB1—kidney cancer	0.00031	0.0111	CbGpPWpGaD
Lomefloxacin—Norfloxacin—CYP1A1—kidney cancer	0.000293	0.311	CrCbGaD
Lomefloxacin—TOP2A—Vincristine—Vinblastine—kidney cancer	0.00029	0.0438	CbGdCrCtD
Lomefloxacin—Sparfloxacin—ABCB1—kidney cancer	0.000273	0.289	CrCbGaD
Lomefloxacin—ABCC2—NRF2 pathway—SLC5A3—kidney cancer	0.000252	0.00903	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000248	0.00891	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—kidney cancer	0.000245	0.00877	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—kidney cancer	0.000242	0.00869	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—SYNE2—kidney cancer	0.000239	0.00857	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—HNF1B—kidney cancer	0.000237	0.00849	CbGpPWpGaD
Lomefloxacin—TOP2A—Vinblastine—Vincristine—kidney cancer	0.000233	0.0353	CbGdCrCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—KCNMA1—kidney cancer	0.000231	0.00827	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—KEAP1—kidney cancer	0.00022	0.00789	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000217	0.00778	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—PSMD7—kidney cancer	0.000216	0.00773	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000216	0.00773	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000216	0.00773	CbGpPWpGaD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—ACHE—kidney cancer	0.000211	0.00757	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—kidney cancer	0.00021	0.00752	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—JUND—kidney cancer	0.000207	0.00742	CbGpPWpGaD
Lomefloxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000205	0.00736	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000204	0.00733	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—MYC—kidney cancer	0.000198	0.00711	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen metabolism—GSTM1—kidney cancer	0.000197	0.00706	CbGpPWpGaD
Lomefloxacin—Levofloxacin—ABCB1—kidney cancer	0.000192	0.204	CrCbGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000192	0.00689	CbGpPWpGaD
Lomefloxacin—TOP2A—Cytarabine—Gemcitabine—kidney cancer	0.00019	0.0288	CbGdCrCtD
Lomefloxacin—CYP1A2—Estrogen metabolism—CYP1A1—kidney cancer	0.000187	0.0067	CbGpPWpGaD
Lomefloxacin—Ciprofloxacin—ABCB1—kidney cancer	0.000186	0.197	CrCbGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000178	0.00638	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUND—kidney cancer	0.000177	0.00635	CbGpPWpGaD
Lomefloxacin—CYP1A2—Xenobiotics—CYP1A1—kidney cancer	0.000172	0.00615	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000165	0.00592	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000163	0.00586	CbGpPWpGaD
Lomefloxacin—TOP2A—Daunorubicin—Doxorubicin—kidney cancer	0.000163	0.0247	CbGdCrCtD
Lomefloxacin—TOP2A—Idarubicin—Doxorubicin—kidney cancer	0.000163	0.0247	CbGdCrCtD
Lomefloxacin—TOP2A—Epirubicin—Doxorubicin—kidney cancer	0.000163	0.0247	CbGdCrCtD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000163	0.00584	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—TP53—kidney cancer	0.000163	0.00584	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—ACY1—kidney cancer	0.000158	0.00566	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—kidney cancer	0.000158	0.00565	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000147	0.00526	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000147	0.00526	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.00014	0.00504	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000137	0.00492	CbGpPWpGaD
Lomefloxacin—TOP2A—Azacitidine—Gemcitabine—kidney cancer	0.000136	0.0207	CbGdCrCtD
Lomefloxacin—Vertigo—Paclitaxel—kidney cancer	0.000134	0.000452	CcSEcCtD
Lomefloxacin—Syncope—Paclitaxel—kidney cancer	0.000134	0.000452	CcSEcCtD
Lomefloxacin—Leukopenia—Paclitaxel—kidney cancer	0.000133	0.000451	CcSEcCtD
Lomefloxacin—Hypersensitivity—Sunitinib—kidney cancer	0.000133	0.000451	CcSEcCtD
Lomefloxacin—Decreased appetite—Vincristine—kidney cancer	0.000133	0.00045	CcSEcCtD
Lomefloxacin—Pruritus—Sorafenib—kidney cancer	0.000133	0.00045	CcSEcCtD
Lomefloxacin—Vomiting—Erlotinib—kidney cancer	0.000133	0.000449	CcSEcCtD
Lomefloxacin—Erythema multiforme—Capecitabine—kidney cancer	0.000133	0.000449	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—SLC5A5—kidney cancer	0.000133	0.00476	CbGpPWpGaD
Lomefloxacin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000132	0.000447	CcSEcCtD
Lomefloxacin—Fatigue—Vincristine—kidney cancer	0.000132	0.000446	CcSEcCtD
Lomefloxacin—Rash—Erlotinib—kidney cancer	0.000132	0.000446	CcSEcCtD
Lomefloxacin—Dermatitis—Erlotinib—kidney cancer	0.000132	0.000445	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—EGR1—kidney cancer	0.000132	0.00472	CbGpPWpGaD
Lomefloxacin—Insomnia—Gemcitabine—kidney cancer	0.000131	0.000444	CcSEcCtD
Lomefloxacin—Headache—Erlotinib—kidney cancer	0.000131	0.000443	CcSEcCtD
Lomefloxacin—Tinnitus—Capecitabine—kidney cancer	0.000131	0.000443	CcSEcCtD
Lomefloxacin—Loss of consciousness—Paclitaxel—kidney cancer	0.000131	0.000443	CcSEcCtD
Lomefloxacin—Constipation—Vincristine—kidney cancer	0.000131	0.000442	CcSEcCtD
Lomefloxacin—Diplopia—Doxorubicin—kidney cancer	0.000131	0.000442	CcSEcCtD
Lomefloxacin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000131	0.000442	CcSEcCtD
Lomefloxacin—Paraesthesia—Gemcitabine—kidney cancer	0.000131	0.000441	CcSEcCtD
Lomefloxacin—Flushing—Capecitabine—kidney cancer	0.00013	0.000441	CcSEcCtD
Lomefloxacin—Cough—Paclitaxel—kidney cancer	0.00013	0.000439	CcSEcCtD
Lomefloxacin—Asthenia—Sunitinib—kidney cancer	0.00013	0.000439	CcSEcCtD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—JUN—kidney cancer	0.00013	0.00466	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Gemcitabine—kidney cancer	0.00013	0.000438	CcSEcCtD
Lomefloxacin—Nausea—Vinblastine—kidney cancer	0.000129	0.000437	CcSEcCtD
Lomefloxacin—Somnolence—Gemcitabine—kidney cancer	0.000129	0.000436	CcSEcCtD
Lomefloxacin—Convulsion—Paclitaxel—kidney cancer	0.000129	0.000436	CcSEcCtD
Lomefloxacin—Nausea—Everolimus—kidney cancer	0.000129	0.000435	CcSEcCtD
Lomefloxacin—Diarrhoea—Sorafenib—kidney cancer	0.000129	0.000435	CcSEcCtD
Lomefloxacin—Hypertension—Paclitaxel—kidney cancer	0.000129	0.000435	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—SLC2A1—kidney cancer	0.000128	0.0046	CbGpPWpGaD
Lomefloxacin—Pruritus—Sunitinib—kidney cancer	0.000128	0.000433	CcSEcCtD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000128	0.00459	CbGpPWpGaD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.000127	0.00457	CbGpPWpGaD
Lomefloxacin—Myalgia—Paclitaxel—kidney cancer	0.000127	0.000429	CcSEcCtD
Lomefloxacin—Chest pain—Paclitaxel—kidney cancer	0.000127	0.000429	CcSEcCtD
Lomefloxacin—Arthralgia—Paclitaxel—kidney cancer	0.000127	0.000429	CcSEcCtD
Lomefloxacin—Anxiety—Paclitaxel—kidney cancer	0.000127	0.000427	CcSEcCtD
Lomefloxacin—Face oedema—Doxorubicin—kidney cancer	0.000126	0.000427	CcSEcCtD
Lomefloxacin—Decreased appetite—Gemcitabine—kidney cancer	0.000126	0.000427	CcSEcCtD
Lomefloxacin—Hypersensitivity—Dactinomycin—kidney cancer	0.000126	0.000427	CcSEcCtD
Lomefloxacin—Chills—Capecitabine—kidney cancer	0.000126	0.000426	CcSEcCtD
Lomefloxacin—Arrhythmia—Capecitabine—kidney cancer	0.000126	0.000424	CcSEcCtD
Lomefloxacin—Discomfort—Paclitaxel—kidney cancer	0.000125	0.000424	CcSEcCtD
Lomefloxacin—Fatigue—Gemcitabine—kidney cancer	0.000125	0.000423	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Vincristine—kidney cancer	0.000125	0.000423	CcSEcCtD
Lomefloxacin—Dizziness—Sorafenib—kidney cancer	0.000125	0.00042	CcSEcCtD
Lomefloxacin—Constipation—Gemcitabine—kidney cancer	0.000124	0.00042	CcSEcCtD
Lomefloxacin—Nausea—Erlotinib—kidney cancer	0.000124	0.00042	CcSEcCtD
Lomefloxacin—Dry mouth—Paclitaxel—kidney cancer	0.000124	0.000419	CcSEcCtD
Lomefloxacin—Diarrhoea—Sunitinib—kidney cancer	0.000124	0.000419	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	0.000124	0.00444	CbGpPWpGaD
Lomefloxacin—Ataxia—Doxorubicin—kidney cancer	0.000123	0.000416	CcSEcCtD
Lomefloxacin—Asthenia—Dactinomycin—kidney cancer	0.000123	0.000416	CcSEcCtD
Lomefloxacin—Confusional state—Paclitaxel—kidney cancer	0.000123	0.000414	CcSEcCtD
Lomefloxacin—Blood creatinine increased—Doxorubicin—kidney cancer	0.000123	0.000414	CcSEcCtD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000122	0.00437	CbGpPWpGaD
Lomefloxacin—Oedema—Paclitaxel—kidney cancer	0.000122	0.000411	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000122	0.000411	CcSEcCtD
Lomefloxacin—Abdominal pain—Vincristine—kidney cancer	0.000121	0.000409	CcSEcCtD
Lomefloxacin—Flatulence—Capecitabine—kidney cancer	0.000121	0.000407	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.00012	0.00432	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—kidney cancer	0.00012	0.00432	CbGpPWpGaD
Lomefloxacin—Dysgeusia—Capecitabine—kidney cancer	0.00012	0.000405	CcSEcCtD
Lomefloxacin—Dizziness—Sunitinib—kidney cancer	0.00012	0.000405	CcSEcCtD
Lomefloxacin—Feeling abnormal—Gemcitabine—kidney cancer	0.00012	0.000404	CcSEcCtD
Lomefloxacin—Shock—Paclitaxel—kidney cancer	0.00012	0.000404	CcSEcCtD
Lomefloxacin—Vomiting—Sorafenib—kidney cancer	0.00012	0.000404	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000119	0.00428	CbGpPWpGaD
Lomefloxacin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000119	0.000402	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—EGR1—kidney cancer	0.000119	0.00427	CbGpPWpGaD
Lomefloxacin—Tachycardia—Paclitaxel—kidney cancer	0.000119	0.000401	CcSEcCtD
Lomefloxacin—Rash—Sorafenib—kidney cancer	0.000119	0.000401	CcSEcCtD
Lomefloxacin—Dermatitis—Sorafenib—kidney cancer	0.000119	0.0004	CcSEcCtD
Lomefloxacin—Back pain—Capecitabine—kidney cancer	0.000118	0.0004	CcSEcCtD
Lomefloxacin—Skin disorder—Paclitaxel—kidney cancer	0.000118	0.000399	CcSEcCtD
Lomefloxacin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000118	0.000398	CcSEcCtD
Lomefloxacin—Headache—Sorafenib—kidney cancer	0.000118	0.000398	CcSEcCtD
Lomefloxacin—Muscle spasms—Capecitabine—kidney cancer	0.000118	0.000397	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Paclitaxel—kidney cancer	0.000118	0.000397	CcSEcCtD
Lomefloxacin—Diarrhoea—Dactinomycin—kidney cancer	0.000117	0.000396	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000117	0.00418	CbGpPWpGaD
Lomefloxacin—Anorexia—Paclitaxel—kidney cancer	0.000116	0.000392	CcSEcCtD
Lomefloxacin—Vomiting—Sunitinib—kidney cancer	0.000115	0.000389	CcSEcCtD
Lomefloxacin—Tremor—Capecitabine—kidney cancer	0.000115	0.000387	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000115	0.00411	CbGpPWpGaD
Lomefloxacin—Rash—Sunitinib—kidney cancer	0.000114	0.000386	CcSEcCtD
Lomefloxacin—Dermatitis—Sunitinib—kidney cancer	0.000114	0.000385	CcSEcCtD
Lomefloxacin—Hypotension—Paclitaxel—kidney cancer	0.000114	0.000384	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Capecitabine—kidney cancer	0.000114	0.000383	CcSEcCtD
Lomefloxacin—Headache—Sunitinib—kidney cancer	0.000113	0.000383	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	0.000113	0.00407	CbGpPWpGaD
Lomefloxacin—Dysphagia—Doxorubicin—kidney cancer	0.000113	0.000382	CcSEcCtD
Lomefloxacin—Anaemia—Capecitabine—kidney cancer	0.000113	0.000382	CcSEcCtD
Lomefloxacin—Hypersensitivity—Vincristine—kidney cancer	0.000113	0.000381	CcSEcCtD
Lomefloxacin—Eosinophilia—Doxorubicin—kidney cancer	0.000112	0.000379	CcSEcCtD
Lomefloxacin—Nausea—Sorafenib—kidney cancer	0.000112	0.000378	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000111	0.000374	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000111	0.00397	CbGpPWpGaD
Lomefloxacin—Malaise—Capecitabine—kidney cancer	0.00011	0.000373	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.00011	0.00396	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.00011	0.00396	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.00011	0.00396	CbGpPWpGaD
Lomefloxacin—Angina pectoris—Doxorubicin—kidney cancer	0.00011	0.000372	CcSEcCtD
Lomefloxacin—Insomnia—Paclitaxel—kidney cancer	0.00011	0.000372	CcSEcCtD
Lomefloxacin—Vertigo—Capecitabine—kidney cancer	0.00011	0.000371	CcSEcCtD
Lomefloxacin—Asthenia—Vincristine—kidney cancer	0.00011	0.000371	CcSEcCtD
Lomefloxacin—Syncope—Capecitabine—kidney cancer	0.00011	0.000371	CcSEcCtD
Lomefloxacin—Leukopenia—Capecitabine—kidney cancer	0.00011	0.00037	CcSEcCtD
Lomefloxacin—Paraesthesia—Paclitaxel—kidney cancer	0.000109	0.000369	CcSEcCtD
Lomefloxacin—Vomiting—Dactinomycin—kidney cancer	0.000109	0.000368	CcSEcCtD
Lomefloxacin—Dyspnoea—Paclitaxel—kidney cancer	0.000109	0.000366	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	0.000108	0.00388	CbGpPWpGaD
Lomefloxacin—Somnolence—Paclitaxel—kidney cancer	0.000108	0.000365	CcSEcCtD
Lomefloxacin—Rash—Dactinomycin—kidney cancer	0.000108	0.000365	CcSEcCtD
Lomefloxacin—Nausea—Sunitinib—kidney cancer	0.000108	0.000363	CcSEcCtD
Lomefloxacin—Loss of consciousness—Capecitabine—kidney cancer	0.000108	0.000363	CcSEcCtD
Lomefloxacin—Dyspepsia—Paclitaxel—kidney cancer	0.000107	0.000362	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—GSTP1—kidney cancer	0.000107	0.00384	CbGpPWpGaD
Lomefloxacin—Cough—Capecitabine—kidney cancer	0.000107	0.000361	CcSEcCtD
Lomefloxacin—Dysuria—Doxorubicin—kidney cancer	0.000106	0.000357	CcSEcCtD
Lomefloxacin—Decreased appetite—Paclitaxel—kidney cancer	0.000106	0.000357	CcSEcCtD
Lomefloxacin—Hypertension—Capecitabine—kidney cancer	0.000106	0.000357	CcSEcCtD
Lomefloxacin—Fatigue—Paclitaxel—kidney cancer	0.000105	0.000354	CcSEcCtD
Lomefloxacin—Diarrhoea—Vincristine—kidney cancer	0.000105	0.000354	CcSEcCtD
Lomefloxacin—Asthenia—Gemcitabine—kidney cancer	0.000104	0.000352	CcSEcCtD
Lomefloxacin—Myalgia—Capecitabine—kidney cancer	0.000104	0.000352	CcSEcCtD
Lomefloxacin—Arthralgia—Capecitabine—kidney cancer	0.000104	0.000352	CcSEcCtD
Lomefloxacin—Chest pain—Capecitabine—kidney cancer	0.000104	0.000352	CcSEcCtD
Lomefloxacin—Constipation—Paclitaxel—kidney cancer	0.000104	0.000351	CcSEcCtD
Lomefloxacin—Anxiety—Capecitabine—kidney cancer	0.000104	0.000351	CcSEcCtD
Lomefloxacin—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000103	0.000349	CcSEcCtD
Lomefloxacin—Discomfort—Capecitabine—kidney cancer	0.000103	0.000348	CcSEcCtD
Lomefloxacin—Pruritus—Gemcitabine—kidney cancer	0.000103	0.000347	CcSEcCtD
Lomefloxacin—Hyperglycaemia—Doxorubicin—kidney cancer	0.000102	0.000345	CcSEcCtD
Lomefloxacin—Dry mouth—Capecitabine—kidney cancer	0.000102	0.000344	CcSEcCtD
Lomefloxacin—Nausea—Dactinomycin—kidney cancer	0.000102	0.000344	CcSEcCtD
Lomefloxacin—Dizziness—Vincristine—kidney cancer	0.000101	0.000342	CcSEcCtD
Lomefloxacin—Confusional state—Capecitabine—kidney cancer	0.000101	0.00034	CcSEcCtD
Lomefloxacin—Feeling abnormal—Paclitaxel—kidney cancer	0.0001	0.000339	CcSEcCtD
Lomefloxacin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.0001	0.000338	CcSEcCtD
Lomefloxacin—Oedema—Capecitabine—kidney cancer	9.99e-05	0.000337	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Paclitaxel—kidney cancer	9.95e-05	0.000336	CcSEcCtD
Lomefloxacin—Diarrhoea—Gemcitabine—kidney cancer	9.95e-05	0.000336	CcSEcCtD
Lomefloxacin—Renal failure—Doxorubicin—kidney cancer	9.92e-05	0.000335	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Doxorubicin—kidney cancer	9.9e-05	0.000334	CcSEcCtD
Lomefloxacin—Stomatitis—Doxorubicin—kidney cancer	9.84e-05	0.000332	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—GSTM1—kidney cancer	9.83e-05	0.00353	CbGpPWpGaD
Lomefloxacin—Shock—Capecitabine—kidney cancer	9.83e-05	0.000332	CcSEcCtD
Lomefloxacin—Conjunctivitis—Doxorubicin—kidney cancer	9.81e-05	0.000331	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Capecitabine—kidney cancer	9.78e-05	0.00033	CcSEcCtD
Lomefloxacin—Tachycardia—Capecitabine—kidney cancer	9.75e-05	0.000329	CcSEcCtD
Lomefloxacin—Vomiting—Vincristine—kidney cancer	9.74e-05	0.000329	CcSEcCtD
Lomefloxacin—Skin disorder—Capecitabine—kidney cancer	9.7e-05	0.000328	CcSEcCtD
Lomefloxacin—Urticaria—Paclitaxel—kidney cancer	9.67e-05	0.000326	CcSEcCtD
Lomefloxacin—Rash—Vincristine—kidney cancer	9.66e-05	0.000326	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Capecitabine—kidney cancer	9.66e-05	0.000326	CcSEcCtD
Lomefloxacin—Dermatitis—Vincristine—kidney cancer	9.65e-05	0.000326	CcSEcCtD
Lomefloxacin—Haematuria—Doxorubicin—kidney cancer	9.63e-05	0.000325	CcSEcCtD
Lomefloxacin—Abdominal pain—Paclitaxel—kidney cancer	9.62e-05	0.000325	CcSEcCtD
Lomefloxacin—Headache—Vincristine—kidney cancer	9.6e-05	0.000324	CcSEcCtD
Lomefloxacin—Epistaxis—Doxorubicin—kidney cancer	9.52e-05	0.000322	CcSEcCtD
Lomefloxacin—Anorexia—Capecitabine—kidney cancer	9.52e-05	0.000321	CcSEcCtD
Lomefloxacin—Agranulocytosis—Doxorubicin—kidney cancer	9.42e-05	0.000318	CcSEcCtD
Lomefloxacin—Hypotension—Capecitabine—kidney cancer	9.33e-05	0.000315	CcSEcCtD
Lomefloxacin—Vomiting—Gemcitabine—kidney cancer	9.24e-05	0.000312	CcSEcCtD
Lomefloxacin—Bradycardia—Doxorubicin—kidney cancer	9.23e-05	0.000312	CcSEcCtD
Lomefloxacin—Rash—Gemcitabine—kidney cancer	9.17e-05	0.000309	CcSEcCtD
Lomefloxacin—Dermatitis—Gemcitabine—kidney cancer	9.16e-05	0.000309	CcSEcCtD
Lomefloxacin—Headache—Gemcitabine—kidney cancer	9.11e-05	0.000308	CcSEcCtD
Lomefloxacin—Nausea—Vincristine—kidney cancer	9.1e-05	0.000307	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.1e-05	0.000307	CcSEcCtD
Lomefloxacin—Rhinitis—Doxorubicin—kidney cancer	9.09e-05	0.000307	CcSEcCtD
Lomefloxacin—Hepatitis—Doxorubicin—kidney cancer	9.06e-05	0.000306	CcSEcCtD
Lomefloxacin—Insomnia—Capecitabine—kidney cancer	9.03e-05	0.000305	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	9.01e-05	0.00323	CbGpPWpGaD
Lomefloxacin—Pharyngitis—Doxorubicin—kidney cancer	8.99e-05	0.000304	CcSEcCtD
Lomefloxacin—Paraesthesia—Capecitabine—kidney cancer	8.97e-05	0.000303	CcSEcCtD
Lomefloxacin—Hypersensitivity—Paclitaxel—kidney cancer	8.97e-05	0.000303	CcSEcCtD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	8.97e-05	0.00321	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Capecitabine—kidney cancer	8.9e-05	0.000301	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—kidney cancer	8.81e-05	0.00316	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—kidney cancer	8.81e-05	0.00316	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—CYP1A1—kidney cancer	8.81e-05	0.00316	CbGpPWpGaD
Lomefloxacin—Dyspepsia—Capecitabine—kidney cancer	8.79e-05	0.000297	CcSEcCtD
Lomefloxacin—Visual impairment—Doxorubicin—kidney cancer	8.73e-05	0.000295	CcSEcCtD
Lomefloxacin—Asthenia—Paclitaxel—kidney cancer	8.73e-05	0.000295	CcSEcCtD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTT1—kidney cancer	8.69e-05	0.00312	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Capecitabine—kidney cancer	8.68e-05	0.000293	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	8.68e-05	0.00311	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—ALDH1A1—kidney cancer	8.65e-05	0.0031	CbGpPWpGaD
Lomefloxacin—Nausea—Gemcitabine—kidney cancer	8.63e-05	0.000292	CcSEcCtD
Lomefloxacin—Fatigue—Capecitabine—kidney cancer	8.61e-05	0.000291	CcSEcCtD
Lomefloxacin—Pruritus—Paclitaxel—kidney cancer	8.61e-05	0.000291	CcSEcCtD
Lomefloxacin—Erythema multiforme—Doxorubicin—kidney cancer	8.57e-05	0.000289	CcSEcCtD
Lomefloxacin—Constipation—Capecitabine—kidney cancer	8.54e-05	0.000288	CcSEcCtD
Lomefloxacin—Tinnitus—Doxorubicin—kidney cancer	8.45e-05	0.000285	CcSEcCtD
Lomefloxacin—Flushing—Doxorubicin—kidney cancer	8.41e-05	0.000284	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	8.41e-05	0.00302	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Paclitaxel—kidney cancer	8.33e-05	0.000281	CcSEcCtD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—CYP1A1—kidney cancer	8.25e-05	0.00296	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Capecitabine—kidney cancer	8.23e-05	0.000278	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Capecitabine—kidney cancer	8.17e-05	0.000276	CcSEcCtD
Lomefloxacin—Chills—Doxorubicin—kidney cancer	8.13e-05	0.000275	CcSEcCtD
Lomefloxacin—Arrhythmia—Doxorubicin—kidney cancer	8.1e-05	0.000273	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ANXA2—kidney cancer	8.07e-05	0.00289	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	8.07e-05	0.00289	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ATP7B—kidney cancer	8.07e-05	0.00289	CbGpPWpGaD
Lomefloxacin—Dizziness—Paclitaxel—kidney cancer	8.05e-05	0.000272	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	7.98e-05	0.00286	CbGpPWpGaD
Lomefloxacin—Urticaria—Capecitabine—kidney cancer	7.93e-05	0.000268	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PSMD7—kidney cancer	7.91e-05	0.00284	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Capecitabine—kidney cancer	7.9e-05	0.000267	CcSEcCtD
Lomefloxacin—Flatulence—Doxorubicin—kidney cancer	7.77e-05	0.000262	CcSEcCtD
Lomefloxacin—Tension—Doxorubicin—kidney cancer	7.74e-05	0.000261	CcSEcCtD
Lomefloxacin—Vomiting—Paclitaxel—kidney cancer	7.74e-05	0.000261	CcSEcCtD
Lomefloxacin—Dysgeusia—Doxorubicin—kidney cancer	7.73e-05	0.000261	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—AURKA—kidney cancer	7.69e-05	0.00276	CbGpPWpGaD
Lomefloxacin—Rash—Paclitaxel—kidney cancer	7.67e-05	0.000259	CcSEcCtD
Lomefloxacin—Dermatitis—Paclitaxel—kidney cancer	7.67e-05	0.000259	CcSEcCtD
Lomefloxacin—Nervousness—Doxorubicin—kidney cancer	7.66e-05	0.000259	CcSEcCtD
Lomefloxacin—Back pain—Doxorubicin—kidney cancer	7.63e-05	0.000258	CcSEcCtD
Lomefloxacin—Headache—Paclitaxel—kidney cancer	7.62e-05	0.000257	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—kidney cancer	7.61e-05	0.00273	CbGpPWpGaD
Lomefloxacin—Muscle spasms—Doxorubicin—kidney cancer	7.58e-05	0.000256	CcSEcCtD
Lomefloxacin—Hypersensitivity—Capecitabine—kidney cancer	7.36e-05	0.000248	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Doxorubicin—kidney cancer	7.32e-05	0.000247	CcSEcCtD
Lomefloxacin—Anaemia—Doxorubicin—kidney cancer	7.29e-05	0.000246	CcSEcCtD
Lomefloxacin—Agitation—Doxorubicin—kidney cancer	7.25e-05	0.000245	CcSEcCtD
Lomefloxacin—Nausea—Paclitaxel—kidney cancer	7.23e-05	0.000244	CcSEcCtD
Lomefloxacin—Asthenia—Capecitabine—kidney cancer	7.17e-05	0.000242	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	7.13e-05	0.00256	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	7.13e-05	0.00256	CbGpPWpGaD
Lomefloxacin—Malaise—Doxorubicin—kidney cancer	7.11e-05	0.00024	CcSEcCtD
Lomefloxacin—Vertigo—Doxorubicin—kidney cancer	7.09e-05	0.000239	CcSEcCtD
Lomefloxacin—Syncope—Doxorubicin—kidney cancer	7.07e-05	0.000239	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—PSMD7—kidney cancer	7.07e-05	0.00254	CbGpPWpGaD
Lomefloxacin—Pruritus—Capecitabine—kidney cancer	7.07e-05	0.000239	CcSEcCtD
Lomefloxacin—Leukopenia—Doxorubicin—kidney cancer	7.06e-05	0.000238	CcSEcCtD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	7.03e-05	0.00252	CbGpPWpGaD
Lomefloxacin—Loss of consciousness—Doxorubicin—kidney cancer	6.93e-05	0.000234	CcSEcCtD
Lomefloxacin—Cough—Doxorubicin—kidney cancer	6.88e-05	0.000232	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—AURKA—kidney cancer	6.88e-05	0.00247	CbGpPWpGaD
Lomefloxacin—Convulsion—Doxorubicin—kidney cancer	6.84e-05	0.000231	CcSEcCtD
Lomefloxacin—Diarrhoea—Capecitabine—kidney cancer	6.83e-05	0.000231	CcSEcCtD
Lomefloxacin—Hypertension—Doxorubicin—kidney cancer	6.81e-05	0.00023	CcSEcCtD
Lomefloxacin—Arthralgia—Doxorubicin—kidney cancer	6.72e-05	0.000227	CcSEcCtD
Lomefloxacin—Myalgia—Doxorubicin—kidney cancer	6.72e-05	0.000227	CcSEcCtD
Lomefloxacin—Chest pain—Doxorubicin—kidney cancer	6.72e-05	0.000227	CcSEcCtD
Lomefloxacin—Anxiety—Doxorubicin—kidney cancer	6.69e-05	0.000226	CcSEcCtD
Lomefloxacin—Discomfort—Doxorubicin—kidney cancer	6.64e-05	0.000224	CcSEcCtD
Lomefloxacin—Dizziness—Capecitabine—kidney cancer	6.6e-05	0.000223	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	6.6e-05	0.00237	CbGpPWpGaD
Lomefloxacin—Dry mouth—Doxorubicin—kidney cancer	6.57e-05	0.000222	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	6.53e-05	0.00234	CbGpPWpGaD
Lomefloxacin—Confusional state—Doxorubicin—kidney cancer	6.49e-05	0.000219	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Doxorubicin—kidney cancer	6.44e-05	0.000217	CcSEcCtD
Lomefloxacin—Oedema—Doxorubicin—kidney cancer	6.44e-05	0.000217	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	6.38e-05	0.00229	CbGpPWpGaD
Lomefloxacin—Vomiting—Capecitabine—kidney cancer	6.35e-05	0.000214	CcSEcCtD
Lomefloxacin—Shock—Doxorubicin—kidney cancer	6.33e-05	0.000214	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Doxorubicin—kidney cancer	6.3e-05	0.000213	CcSEcCtD
Lomefloxacin—Rash—Capecitabine—kidney cancer	6.3e-05	0.000213	CcSEcCtD
Lomefloxacin—Dermatitis—Capecitabine—kidney cancer	6.29e-05	0.000212	CcSEcCtD
Lomefloxacin—Tachycardia—Doxorubicin—kidney cancer	6.28e-05	0.000212	CcSEcCtD
Lomefloxacin—Headache—Capecitabine—kidney cancer	6.26e-05	0.000211	CcSEcCtD
Lomefloxacin—Skin disorder—Doxorubicin—kidney cancer	6.25e-05	0.000211	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Doxorubicin—kidney cancer	6.22e-05	0.00021	CcSEcCtD
Lomefloxacin—Anorexia—Doxorubicin—kidney cancer	6.14e-05	0.000207	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—kidney cancer	6.11e-05	0.00219	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	6.05e-05	0.00217	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTP1—kidney cancer	6.02e-05	0.00216	CbGpPWpGaD
Lomefloxacin—Hypotension—Doxorubicin—kidney cancer	6.02e-05	0.000203	CcSEcCtD
Lomefloxacin—Nausea—Capecitabine—kidney cancer	5.93e-05	0.0002	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.87e-05	0.000198	CcSEcCtD
Lomefloxacin—Insomnia—Doxorubicin—kidney cancer	5.82e-05	0.000197	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.82e-05	0.00209	CbGpPWpGaD
Lomefloxacin—Paraesthesia—Doxorubicin—kidney cancer	5.78e-05	0.000195	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—kidney cancer	5.78e-05	0.00207	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.78e-05	0.00207	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	5.77e-05	0.00207	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	5.76e-05	0.00206	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Doxorubicin—kidney cancer	5.74e-05	0.000194	CcSEcCtD
Lomefloxacin—Somnolence—Doxorubicin—kidney cancer	5.72e-05	0.000193	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	5.71e-05	0.00205	CbGpPWpGaD
Lomefloxacin—Dyspepsia—Doxorubicin—kidney cancer	5.67e-05	0.000191	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.62e-05	0.00202	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Doxorubicin—kidney cancer	5.6e-05	0.000189	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	5.57e-05	0.002	CbGpPWpGaD
Lomefloxacin—Fatigue—Doxorubicin—kidney cancer	5.55e-05	0.000187	CcSEcCtD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTM1—kidney cancer	5.53e-05	0.00198	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—JUN—kidney cancer	5.53e-05	0.00198	CbGpPWpGaD
Lomefloxacin—Constipation—Doxorubicin—kidney cancer	5.51e-05	0.000186	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	5.42e-05	0.00194	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	5.39e-05	0.00193	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PTEN—kidney cancer	5.35e-05	0.00192	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.31e-05	0.00191	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Doxorubicin—kidney cancer	5.31e-05	0.000179	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Doxorubicin—kidney cancer	5.26e-05	0.000178	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	5.24e-05	0.00188	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—BRCA2—kidney cancer	5.21e-05	0.00187	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2B—kidney cancer	5.17e-05	0.00185	CbGpPWpGaD
Lomefloxacin—Urticaria—Doxorubicin—kidney cancer	5.11e-05	0.000173	CcSEcCtD
Lomefloxacin—Abdominal pain—Doxorubicin—kidney cancer	5.09e-05	0.000172	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—GSTT1—kidney cancer	5.08e-05	0.00182	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	5.03e-05	0.0018	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—kidney cancer	4.99e-05	0.00179	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	4.96e-05	0.00178	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	4.96e-05	0.00178	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	4.9e-05	0.00176	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	4.86e-05	0.00174	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—PTGS1—kidney cancer	4.76e-05	0.00171	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	4.76e-05	0.00171	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Doxorubicin—kidney cancer	4.74e-05	0.00016	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	4.73e-05	0.00169	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	4.63e-05	0.00166	CbGpPWpGaD
Lomefloxacin—Asthenia—Doxorubicin—kidney cancer	4.62e-05	0.000156	CcSEcCtD
Lomefloxacin—Pruritus—Doxorubicin—kidney cancer	4.56e-05	0.000154	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	4.53e-05	0.00162	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—BIRC5—kidney cancer	4.46e-05	0.0016	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.44e-05	0.00159	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Doxorubicin—kidney cancer	4.41e-05	0.000149	CcSEcCtD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.31e-05	0.00154	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.28e-05	0.00153	CbGpPWpGaD
Lomefloxacin—Dizziness—Doxorubicin—kidney cancer	4.26e-05	0.000144	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.25e-05	0.00153	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	4.2e-05	0.00151	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	4.13e-05	0.00148	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.11e-05	0.00147	CbGpPWpGaD
Lomefloxacin—Vomiting—Doxorubicin—kidney cancer	4.09e-05	0.000138	CcSEcCtD
Lomefloxacin—Rash—Doxorubicin—kidney cancer	4.06e-05	0.000137	CcSEcCtD
Lomefloxacin—Dermatitis—Doxorubicin—kidney cancer	4.06e-05	0.000137	CcSEcCtD
Lomefloxacin—Headache—Doxorubicin—kidney cancer	4.03e-05	0.000136	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.93e-05	0.00141	CbGpPWpGaD
Lomefloxacin—Nausea—Doxorubicin—kidney cancer	3.82e-05	0.000129	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	3.8e-05	0.00136	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	3.8e-05	0.00136	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	3.72e-05	0.00133	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TP53—kidney cancer	3.65e-05	0.00131	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTP1—kidney cancer	3.52e-05	0.00126	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	3.51e-05	0.00126	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	3.47e-05	0.00125	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—kidney cancer	3.31e-05	0.00119	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.24e-05	0.00116	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTM1—kidney cancer	3.24e-05	0.00116	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	3.19e-05	0.00114	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	3.07e-05	0.0011	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	3.03e-05	0.00109	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2A—kidney cancer	2.96e-05	0.00106	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—kidney cancer	2.93e-05	0.00105	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—kidney cancer	2.79e-05	0.001	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ACY1—kidney cancer	2.7e-05	0.000968	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN1B—kidney cancer	2.62e-05	0.000939	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—kidney cancer	2.51e-05	0.0009	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCND1—kidney cancer	2.5e-05	0.000895	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—kidney cancer	2.3e-05	0.000826	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.3e-05	0.000825	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PDHB—kidney cancer	2.3e-05	0.000823	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—POMC—kidney cancer	2.29e-05	0.00082	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—kidney cancer	2.24e-05	0.000803	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—kidney cancer	2.19e-05	0.000786	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CCBL1—kidney cancer	2.16e-05	0.000774	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MAPK3—kidney cancer	2.06e-05	0.000738	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MYC—kidney cancer	2e-05	0.000718	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MAPK1—kidney cancer	1.96e-05	0.000703	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.95e-05	0.0007	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.87e-05	0.000671	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPAT—kidney cancer	1.87e-05	0.000671	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.85e-05	0.000662	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.84e-05	0.000658	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.83e-05	0.000656	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APRT—kidney cancer	1.74e-05	0.000624	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—FH—kidney cancer	1.74e-05	0.000624	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.7e-05	0.00061	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TP53—kidney cancer	1.64e-05	0.00059	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GPC3—kidney cancer	1.64e-05	0.000586	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CA2—kidney cancer	1.59e-05	0.00057	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALAD—kidney cancer	1.55e-05	0.000556	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.51e-05	0.000543	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.48e-05	0.00053	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PGK1—kidney cancer	1.42e-05	0.000508	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.42e-05	0.000508	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LDHB—kidney cancer	1.39e-05	0.000499	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CA9—kidney cancer	1.21e-05	0.000432	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.18e-05	0.000423	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CRABP1—kidney cancer	1.03e-05	0.000368	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ITPR2—kidney cancer	9.53e-06	0.000342	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.79e-06	0.000315	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ACHE—kidney cancer	8.69e-06	0.000312	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTT1—kidney cancer	8.69e-06	0.000312	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SCARB1—kidney cancer	8.23e-06	0.000295	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS1—kidney cancer	8.14e-06	0.000292	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PSMD7—kidney cancer	7.99e-06	0.000286	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—BCHE—kidney cancer	7.57e-06	0.000271	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC5A5—kidney cancer	7.48e-06	0.000268	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC2A1—kidney cancer	7.22e-06	0.000259	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.01e-06	0.000251	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.11e-06	0.000219	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTP1—kidney cancer	6.02e-06	0.000216	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCB1—kidney cancer	5.7e-06	0.000204	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTM1—kidney cancer	5.54e-06	0.000199	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP1A1—kidney cancer	5.25e-06	0.000188	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.31e-06	0.000155	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—POMC—kidney cancer	3.91e-06	0.00014	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS2—kidney cancer	3.12e-06	0.000112	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTEN—kidney cancer	2.72e-06	9.76e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.92e-06	6.89e-05	CbGpPWpGaD
